Clinical Efficacy and Myokine Profiling Through Targeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Carcinoma: A Stratified Randomized Pilot Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07883161

Title field or adapter rule

{'original_value': 'Clinical Efficacy and Myokine Profiling Through Targeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Carcinoma: A Stratified Randomized Pilot Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:22.852391+00:00

Published At

2026-10-20T00:00:00+00:00

Record Updated At

2026-10-20

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["PDAC", "Pancreas Adenocarcinoma (MSI-H)"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-20", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07883161"

protocolSection.identificationModule.officialTitle

"Clinical Efficacy and Myokine Profiling Through Targeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Carcinoma: A Stratified Randomized Pilot Trial"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• PDAC (protocolSection.conditionsModule.conditions)
• Pancreas Adenocarcinoma (MSI-H) (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Oral Nutritional Supplement', 'Standard Dietary Counseling'], 'description': 'Oral administration of Abound, 2 sachets per day dissolved in water, preferably between meals. Total daily intake: 14.8 g L-Glutamine, 14.8 g L-Arginine, and 2.6 g beta-hydroxy-beta-methylbutyrate (HMB). Administered starting 7-10 days before cycle 1 of chemotherapy through day 60.', 'name': 'HMB / L-Arginine / L-Glutamine oral nutritional mixture', 'type': 'DIETARY_SUPPLEMENT'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Standard Dietary Counseling'], 'description': 'Standardized individualized dietary counseling provided by clinical dietitians to ensure adequate caloric and protein intake according to clinical guidelines throughout the 60 days of observation.', 'name': 'Standard Dietary Counseling', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.